The effect of aminoguanidine (AG) on the expression of adhesion molecu
les on nonactivated human umbilical vein endothelial cells (HUVEC) was
investigated in vitro, Nonactivated HUVEC cultivated on long-term gly
cated fibronectin (FN) as compared to native FN showed a significant u
pregulation of intercellular adhesion molecule 1 (ICAM-1), vascular ce
ll adhesion molecule I (VCAM-1) and CD31 which could be further promot
ed by long-term glycated bovine serum albumin. AG, at a concentration
of 0.01 mol/l, caused an upregulation of ICAM-1 of 48 +/- 17.4% in HUV
EC cultivated on gelatin. In contrast, VCAM-1 and E-selectin remained
unaffected, At this concentration, formation of advanced glycation end
products (AGE) was inhibited by 57%, as determined immunologically, a
nd by 50%, as verified by AGE-specific fluorescence. A hypothesis conc
erning the upregulation of ICAM-1 by AG as compared to VCAM-1 is propo
sed relating to its relative redox insensitivity. Our results demonstr
ate that the beneficial effect of AG in reducing the risk of accelerat
ed development of atherosclerosis in diabetic patients by inhibiting f
ormation of AGE on matrix proteins such as FN might be hampered by its
tendency to upregulate ICAM-1 on endothelial cells.